Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor system
Journal Article
·
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
The nitroimidazole radiosensitizers SR 2508 and Ro 03-8799 have different dose-limiting toxicities in man and hence can be used in combination. Such therapy will be beneficial only if their radiosensitizing properties are additive, which this study sought to determine using clinically relevant radiosensitizer concentrations in the EMT6 tumor in the flanks of BALB/c mice. 240 mg/kg of each drug gave tumor concentrations (+/- 2 se) 55 min after i.v. administration of the combination of 50.4 +/- 10.6 micrograms/g (236 +/- 50 nmol/g) for SR 2508 and 39.7 +/- 9.0 micrograms/g (137 +/- 31 nmol/g) for Ro 03-8799. The radiosensitization by both agents administered both singly and in combination at 240 mg/kg and singly at 480 mg/kg was measured, giving sensitizers 30 min before 20 Gy of 250 kV X rays. Tumor response was assayed by clonogenic cell survival. SER values (with 95% confidence limits) were 1.28 (1.20-1.37) for 240 mg/kg SR 2508, 1.20 (1.10-1.30) for 240 mg/kg Ro 03-8799, 1.46 (1.33-1.59) for 240 mg/kg of both drugs in combination, 1.46 (1.38-1.55) for 480 mg/kg SR 2508 and 1.46 (1.31-1.62) for 480 mg/kg Ro 03-8799. These data confirm the additivity of radiosensitization by the two drugs administered in combination.
- Research Organization:
- Univ. Department of Clinical Oncology and Radiotherapeutics, Cambridge (England)
- OSTI ID:
- 7053073
- Journal Information:
- Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 15:3; ISSN IOBPD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Multiple dose study of the combined radiosensitizers Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)
Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)
Abnormal clinical pharmacokinetics of the developmental radiosensitizers pimonidazole (Ro 03-8799) and etanidazole (SR 2508)
Journal Article
·
Fri Mar 31 23:00:00 EST 1989
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6148042
Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)
Journal Article
·
Thu Sep 01 00:00:00 EDT 1988
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6699515
Abnormal clinical pharmacokinetics of the developmental radiosensitizers pimonidazole (Ro 03-8799) and etanidazole (SR 2508)
Journal Article
·
Tue May 01 00:00:00 EDT 1990
· International Journal of Radiation Oncology, Biology and Physics; (USA)
·
OSTI ID:7062251
Related Subjects
550603 -- Medicine-- External Radiation in Therapy-- (1980-)
560152* -- Radiation Effects on Animals-- Animals
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMALS
DRUGS
ELECTROMAGNETIC RADIATION
EVALUATION
EXPERIMENTAL NEOPLASMS
IONIZING RADIATIONS
MAMMALS
MEDICINE
MICE
NUCLEAR MEDICINE
RADIATIONS
RADIOLOGY
RADIOSENSITIZERS
RADIOTHERAPY
RODENTS
SURVIVAL CURVES
THERAPY
VERTEBRATES
X RADIATION
560152* -- Radiation Effects on Animals-- Animals
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMALS
DRUGS
ELECTROMAGNETIC RADIATION
EVALUATION
EXPERIMENTAL NEOPLASMS
IONIZING RADIATIONS
MAMMALS
MEDICINE
MICE
NUCLEAR MEDICINE
RADIATIONS
RADIOLOGY
RADIOSENSITIZERS
RADIOTHERAPY
RODENTS
SURVIVAL CURVES
THERAPY
VERTEBRATES
X RADIATION